(2021). Nt-Probnp in Assessment of Severity of Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome. test, 5(1), -. doi: 10.21608/cvrepj.2021.351600
. "Nt-Probnp in Assessment of Severity of Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome". test, 5, 1, 2021, -. doi: 10.21608/cvrepj.2021.351600
(2021). 'Nt-Probnp in Assessment of Severity of Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome', test, 5(1), pp. -. doi: 10.21608/cvrepj.2021.351600
Nt-Probnp in Assessment of Severity of Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome. test, 2021; 5(1): -. doi: 10.21608/cvrepj.2021.351600

Nt-Probnp in Assessment of Severity of Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome

Cardiovascular Research Prove Journal
Volume 5, Issue 1, June 2021    PDF (51.92 K)
Document Type: Abstracts
DOI: 10.21608/cvrepj.2021.351600
Abstract
The aim of this study was to compare serum NtproBNP levels in NSTE-ACS patients and controls 
and to assess the relation between serum N-terminal 
pro brain natriuretic peptide (Nt- proBNP) and the 
severity of coronary artery disease (CAD) in 
patients with non-ST elevation acute coronary 
syndrome NSTE-ACS [unstable angina and 
NSTEMI].
Statistics
Article View: 37
PDF Download: 31